Vaxart, Inc.

( )
VXRT After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
Health Technology » Biotechnology
MRNAModerna, Inc. -0.59%160.430.0%$1785.47m
OCGNOcugen, Inc. -1.71%8.600.0%$1110.21m
BNTXBioNTech SE 2.87%198.300.0%$880.73m
AMGNAmgen, Inc. 0.40%252.381.3%$741.37m
NVAXNovavax, Inc. 6.43%140.1679.8%$613.90m
SNSSSunesis Pharmaceuticals, Inc. 6.90%8.210.7%$573.91m
GILDGilead Sciences, Inc. 0.79%69.071.0%$509.27m
REGNRegeneron Pharmaceuticals, Inc. 1.38%523.732.7%$424.50m
ALXNAlexion Pharmaceuticals, Inc. 0.73%174.752.0%$370.86m
VRTXVertex Pharmaceuticals, Inc. -0.34%216.351.9%$297.96m
ILMNIllumina, Inc. -0.41%379.483.5%$290.64m
BIIBBiogen, Inc. 0.07%280.401.7%$268.65m
VXRTVaxart, Inc. -2.72%6.430.0%$244.65m
CRSPCRISPR Therapeutics AG 2.42%109.220.6%$178.48m
BNGOBionano Genomics, Inc. 3.70%5.600.0%$175.20m

Company Profile

Vaxart, Inc. operates as a clinical-stage biotechnology company, which engages in the development of oral recombinant vaccines. Its products include Influenza, Norovirus and Respiratory Syncytial Virus. The company was founded in 2004 and is headquartered in South San Francisco, CA.